My urologist is recommending Degarelix for 3 months as my 3rd round of hormone rx. I was diagnosed in 1999, only rx is hormone rx and I’m 80. One concern is the different dosages given in the trials. Your opinion?

. My urologist is recommending Degarelix for 3 months as my 3rd round of hormone rx. I was diagnosed in 1999, only rx is hormone rx and I'm 80. One concern is the different dosages given in the trials. Your opinion?

Degarelix has a reasonable role to play as initial treatment for prostate cancer as it causes a more rapid drop in testosterone. However, I am not aware of any advantages at all to Degarelix in the third round. The only exception would be if Lupron and related drugs were unable to reduce the testosterone sufficiently.
Disclaimer:

This information on this site is advisory only and not a substitute for medical treatment; please consult your physician for specific medical or therapeutic advice.

Ask Dr. Espinosa

Geo Espinosa, N.D., L.Ac, CNS, RH (AHG) is the Director of the Integrative Urological Center at New York University Langone Medical Center. Before joining NYU, Dr. Espinosa was a clinician, researcher and director of clinical trials at the Center for Holistic Urology at Columbia University Medical Center. He is a licensed naturopathic doctor, licensed acupuncturist, a Certified Nutrition Specialist and a Registered Herbalist. Dr. Espinosa is an author of the naturopathic entry in 1000 Cures for 200 ailments, by Harper Collins; March 2007 and “Prostate cancer – Nutrients that may slow its progression,” Food and Nutrients in Disease Management - Maryland: Cadmus Publishing, 2009.

Ask Dr. Myers

Medical oncologist and prostate cancer survivor, Dr Charles "Snuffy" Myers was a key player in creating AZT, Suranim, and Phenylacetate while working at the National Institute of Health. With over 250 research papers published, Myers is one of the leading developers of today's prostate cancer canon on both the research and treatment side of the test tube. Former Cancer Director at the University of Virginia, Myers opened the American Institute for Diseases of the Prostate in 2002 to provide men with the kind of comprehensive care that saved his own life. Dr. Myers has long been popular among prostate cancer patients as a speaker because of his ability to explain science and medicine in easy-to-understand language.

Ask Dr. Latini

Dr. Latini welcomes your questions about the psycho-social dimensions of Prostate Cancer, particularly those presented by Gay and Bisexual men. Dr. Latini is an assistant professor of urology at Baylor College of Medicine. Before joining Baylor, he spent six years in the Department of Urology at the University of California, San Francisco. Dr. Latini is a clinical health psychologist whose work concentrates on cancer survivorship and symptom management for persons living with genitourinary cancer.